drugset / Trial / NCT00628472

Novel Technique for Botulinum Toxin Injection to Minimize Patient Discomfort

NCT00628472

Completed 21 enrolled Henry Ford Health System
RandomizedSingle-groupSingle-blindSupportive care

Summary

This single blinded randomized pilot study was performed on 21 Caucasian females to determine if injections through follicular openings were less painful than traditional injections for cosmetic botulinum toxin type A injections.

Timeline

Start
2007-01
Primary completion
2007-05
Completion
2007-05

Drugs

EvaluationDrugModalityDoseRoute
Background Botulinum toxin type A Protein / enzyme biologic 12 iu

Indications

No indication recorded.